<DOC>
	<DOCNO>NCT00795717</DOCNO>
	<brief_summary>The purpose study determine whether fish oil supplementation Lovaza , formally know Omacor result significant reduction serum triglyceride ( TG ) , increase high density lipoprotein ( HDL ) , improvement endothelial dysfunction .</brief_summary>
	<brief_title>Human Immunodeficiency Virus ( HIV ) , Arterial Dysfunction , Lipids , Lovaza ( HALO ) Trial</brief_title>
	<detailed_description>This randomize , double blind , placebo control , cross-over , clinical trial determine effect fish oil supplementation LovazaÂ® triglyceride level HIV-infected subject HAART elevate serum triglyceride . The sample size 40 subject . The total duration study 28 week , 12-week treatment period separate 4-week washout . This study conduct Clinical Research Center Tufts Medical Center .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>HIVinfected men woman least 18 year age On stable HAART previous three month without anticipated change HAART regimen throughout duration study Fasting triglycerides &gt; 150 mg/dl &lt; 1,500 mg/dl Participants may lipid lower therapy ; lipid lowering therapy , therapy must stable 8 week change course study Participants may beta blocker ( e.g. , Atenolol , Metoprolol , Propranolol ) , Estrogens ( e.g. , Estinyl ; Estrace ; Estraderm ) Thiazides ( water pill ) , however therapy agent must stable 8 week start study alter study unless deem medically necessary participant 's medical provider approve Dr. Wanke Female participant reproductive age must pregnant ( negative test ) lactate screen throughout trial agree use 2 method barrier contraception course trial 2 month trial unless surgically sterilize ( tubal ligation hysterectomy ) , postmenopausal menses &gt; 1 year Ability provide consent Plasma HIV1 RNA &gt; 10,000 Previous history atherosclerotic disease diabetes mellitus Change HAART regimen three month prior study entry Change lipid lower therapy within 2 month On chronic anticoagulant heparin coumadin On fish oil , omega 3 supplement , Omacor currently past month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>atherogenic lipid profile</keyword>
	<keyword>brachial artery reactivity</keyword>
	<keyword>omega three fatty acid</keyword>
</DOC>